Does income protection pay out for cancer?
Yes — cancer is one of the most common reasons people make income protection claims. If a cancer diagnosis or its treatment (surgery, chemotherapy, radiotherapy) prevents you from working, your income protection policy will pay out — subject to the deferred period passing and the "own occupation" definition being met.
How income protection handles cancer claims
- You receive a cancer diagnosis and become unable to work due to the illness or treatment
- Your deferred period begins (typically 4, 8, 13, or 26 weeks)
- Once the deferred period has passed, monthly benefit payments begin
- Payments continue until you return to work, the policy end date, or you die
Cancer IP claims — average duration
The average income protection claim lasts over 5 years. Cancer-related claims can last from a few months (for early-stage cancers with straightforward treatment) to many years for more serious diagnoses requiring long-term treatment or with permanent effects on working capacity.
What if I have a history of cancer?
Getting income protection after a cancer diagnosis or during remission is more complex. Many standard insurers will apply a cancer exclusion — covering all other causes of inability to work, but excluding cancer-related claims. Some specialist insurers offer broader terms for cancer survivors in remission. The further from treatment completion, the better the prospects.
IP vs critical illness cover for cancer
- Income protection: Pays monthly while you cannot work. Stops when you return to work.
- Critical illness cover: Pays a lump sum on cancer diagnosis, regardless of whether you can work.
Both serve different purposes — many people benefit from having both.
Frequently Asked Questions
Only if you're actually unable to work. IP pays when you cannot perform your own occupation due to illness — if you can continue working through treatment, a claim would not be valid.
Yes, but most insurers apply a cancer exclusion during and after treatment. Some specialist insurers offer broader cover for cancer survivors in established remission. A whole-of-market broker can identify the best available options.